Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

OctoPlus NV Updates on Dr. Reddy's Laboratories Ltd Reddy Netherlands B.V. Offer for OctoPlus NV's Shares


Monday, 11 Feb 2013 11:01pm EST 

OctoPlus NV announced that Reddy Netherlands B.V. (the Offeror), a wholly owned subsidiary of Dr.Reddy's Laboratories Ltd has declared the Offer for the Company's shares unconditional. 70.7% of the Shares have been tendered under the Offer, which together with Shares acquired by the Offeror during the Offer Period represent in total 92.7% of the Shares. The settlement of the Offer will take place on February 15, 2013. The Shareholders can still tender their Shares during a Post Closing Acceptance Period starting on February 13, 2013 and ending on February 26, 2013. The Offeror intends to acquire all Shares of the Company and to terminate the Company's listing on NYSE Euronext Amsterdam. 

Company Quote

52.29
1.36 +2.67%
31 Oct 2014